We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Teva Reinforces Leadership Position in CNS with Acquisition of Auspex

News   Apr 02, 2015

 
Teva Reinforces Leadership Position in CNS with Acquisition of Auspex
 
 
Advertisement
 

RELATED ARTICLES

Mixing COVID-19 Vaccines Increases Side Effects, Preliminary Data Suggests

News

Leaders of the Com-COV study share preliminary findings that suggest combining different COVID-19 vaccines increases the reactogenicity (side effect profile) associated with vaccination.

READ MORE

Gene Therapy for Children Born Without an Immune System

News

An investigational gene therapy can safely restore the immune systems of infants and children who have a rare, life-threatening inherited immunodeficiency disorder, according to research supported in part by the National Institutes of Health.

READ MORE

Second Possible Effective Mechanism of Remdesivir Discovered

News

SARS-CoV-2 suppresses host cell defense mechanisms using the virus protein nsP3. Using structural analyses, researchers have discovered that a decomposition product of the virostatic agent remdesivir binds to nsP3.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE